Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds
data privacy protection Impressum
Home
About us
Organization & Management
Administration
Innovation Management

About us

Innovation Management

Bridging the gap between research and industry
© DKFZ

Innovation Management – A Biotech Approach to Technology Transfer

Contact us

innovation@dkfz.de

The Innovation Management (IM) team at DKFZ propels groundbreaking cancer research into practical, impactful applications, actively supporting researchers and industry partners in advancing discoveries that benefit patients and society. Across five specialized groups (see below) IM secures and develops intellectual property, builds alliances, and drives entrepreneurial ventures that bring pioneering therapies to the forefront. Under the strategic leadership of Chief Innovation Officer Rainer Wessel, IM orchestrates the transition from concept to cure, reinforcing DKFZ's role as a driving force for innovation, entrepreneurship, and progress in the battle against cancer.

© dkfz.de

Team Innovation Management

Rainer Wessel brings a wealth of experience in innovation management and technology transfer, having led multiple initiatives bridging scientific discovery with industry applications. Known for his strategic approach and hands-on leadership, he has a proven track record of fostering collaborations that drive impactful solutions in the life sciences sector. As Chief Innovation Officer at DKFZ, he leads the Innovation Management team with a focus on accelerating cancer research advancements for patient benefit. His passion for precision and resilience shapes DKFZ's approach to innovation.
"In the field of innovation, our mission is to deploy every resource strategically and press forward with precision—because every breakthrough is a step closer to victory in the fight against cancer."
Frieder Kern heads this group, focused on empowering innovative spin-offs and fostering entrepreneurial spirit within DKFZ. With guidance on equity, funding strategies, and hands-on startup support, they advance pioneering ventures, transforming cutting-edge research into sustainable businesses that benefit cancer patients worldwide.
Led by Ruth Herzog, this group develops and shares information on DKFZ's research and innovation initiatives. They manage internal and external communication, ensuring that achievements in cancer research reach relevant stakeholders, including the scientific community, industry partners, and policymakers. Their work reinforces DKFZ's role in translating research into applications that benefit society.

Led by Dirk Kuck this group expertly navigates the lifecycle of DKFZ's research projects, from initial validation to product development. Their focus on strategy and efficient project execution ensures that promising research moves seamlessly through development stages, bringing innovative cancer therapies closer to market.
Led by Karin Flieger, this group is dedicated to safeguarding DKFZ's intellectual property through robust patent strategies and technical contracts. They secure the foundations of collaboration by ensuring confidentiality and compliance in material transfer and license agreements. This team provides essential support for navigating the legal landscape to protect innovations at every stage.
Guided by Holger Hess-Stumpp, the Business Development team connects DKFZ with industry partners, creating avenues for cooperation that accelerate cancer research breakthroughs. By assessing market potential and identifying commercialization opportunities, they bridge scientific excellence with industry impact, establishing DKFZ as a trusted research partner.

Search Technologies

Go to IN-PART

Explore innovative technologies and connect with unique licensing and partnership opportunities to drive your business forward. Powered by IN-PART.

General Terms and Conditions for the execution of research and development orders in the Deutsches Krebsforschungszentrum (German Cancer Research Center) Heidelberg,

Status: January 2019 Terms and Conditions (English). Status: April 2019 Terms and Conditions, AGBs (Deutsch).

to top
powered by webEdition CMS